Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Summary

This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.

Timeline

Start

2025-06

Primary completion

2027-12

Completion

2040-06

Drugs

Indications